These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24930498)

  • 21. The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.
    Viasus D; Garcia-Vidal C; Simonetti AF; Dorca J; Llopis F; Mestre M; Morandeira-Rego F; Carratalà J
    BMJ Open; 2015 Jan; 5(1):e006251. PubMed ID: 25564143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic cytokines and chemokines on admission of children hospitalized with community-acquired pneumonia.
    Vasconcellos ÂG; Clarêncio J; Andrade D; Cardoso MA; Barral A; Nascimento-Carvalho CM
    Cytokine; 2018 Jul; 107():1-8. PubMed ID: 29158121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia.
    Glynn P; Coakley R; Kilgallen I; Murphy N; O'Neill S
    Thorax; 1999 Jan; 54(1):51-5. PubMed ID: 10343632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations between extent of X-ray infiltration and levels of serum C-reactive protein in adult non-severe community-acquired pneumonia.
    Tamayose M; Fujita J; Parrott G; Miyagi K; Maeshiro T; Hirata T; Higa F; Tateyama M; Watanabe A; Aoki N; Niki Y; Kadota J; Yanagihara K; Kaku M; Hori S; Kohno S
    J Infect Chemother; 2015 Jun; 21(6):456-63. PubMed ID: 25817351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].
    Christ-Crain M; Morgenthaler NG; Stolz D; Müller C; Bingisser R; Harbarth S; Tamm M; Struck J; Bergmann A; Müller B
    Crit Care; 2006; 10(3):R96. PubMed ID: 16805922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Severity scores for predicting clinically relevant outcomes for immunocompetent adult patients hospitalized with community-acquired pneumococcal pneumonia].
    Saldías F; Díaz O
    Rev Chilena Infectol; 2011 Aug; 28(4):303-9. PubMed ID: 22052393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity is associated with improved survival in community-acquired pneumonia.
    Singanayagam A; Singanayagam A; Chalmers JD
    Eur Respir J; 2013 Jul; 42(1):180-7. PubMed ID: 23222873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.
    Lui G; Ip M; Lee N; Rainer TH; Man SY; Cockram CS; Antonio GE; Ng MH; Chan MH; Chau SS; Mak P; Chan PK; Ahuja AT; Sung JJ; Hui DS
    Respirology; 2009 Nov; 14(8):1098-105. PubMed ID: 19818051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T helper 17 cells are involved in the local and systemic inflammatory response in community-acquired pneumonia.
    Paats MS; Bergen IM; Hanselaar WE; van Zoelen EC; Verbrugh HA; Hoogsteden HC; van den Blink B; Hendriks RW; van der Eerden MM
    Thorax; 2013 May; 68(5):468-74. PubMed ID: 23315492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine levels predict 30-day mortality in octogenarians and nonagenarians with community-acquired pneumonia: a retrospective observational study.
    Pinargote-Celorio H; Miralles G; Cano M; Caparros E; Portilla J; González-Alcaide G; Ramos Rincón JM
    Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):299-307. PubMed ID: 31758443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nutritional parameters affecting severity of pneumonia and length of hospital stay in patients with pneumococcal pneumonia: a retrospective cross-sectional study.
    Akuzawa N; Naito H
    BMC Pulm Med; 2015 Nov; 15():149. PubMed ID: 26608261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of age and comorbidities on serum levels of inflammatory markers in community-acquired pneumonia.
    Viasus D; Simonetti AF; Estupiñan-Bohórquez AF; Carratalà J
    Eur J Clin Invest; 2021 Jun; 51(6):e13480. PubMed ID: 33350464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term survival of immunocompetent patients older than 60 years hospitalized for community-acquired pneumonia].
    Saldías P F; Maturana O R; Román O F; Díaz P O
    Rev Med Chil; 2013 Jul; 141(7):831-43. PubMed ID: 24356731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of length of stay between the young and aged in hospitalized community-acquired pneumonia patients.
    Kaysar M; Augustine T; Jim L; Benjamin C
    Geriatr Gerontol Int; 2008 Dec; 8(4):227-33. PubMed ID: 19149833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis.
    Angus DC; Yang L; Kong L; Kellum JA; Delude RL; Tracey KJ; Weissfeld L;
    Crit Care Med; 2007 Apr; 35(4):1061-7. PubMed ID: 17334246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes.
    Cillóniz C; Ewig S; Polverino E; Muñoz-Almagro C; Marco F; Gabarrús A; Menéndez R; Mensa J; Torres A
    Clin Microbiol Infect; 2012 Nov; 18(11):1134-42. PubMed ID: 22044658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Factors effecting the duration of hospitalization and mortality in patients with community-acquired pneumonia].
    Pişkin N; Aydemir H; Oztoprak N; Akduman D; Celebi G; Seremet Keskin A
    Mikrobiyol Bul; 2009 Oct; 43(4):597-606. PubMed ID: 20084912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of clinical features and outcomes of hospitalized adult patients with novel influenza A (H1N1) pneumonia and other pneumonia.
    Sohn CH; Ryoo SM; Yoon JY; Seo DW; Lim KS; Kim SH; Hong SB; Lim CM; Koh YS; Kim WY
    Acad Emerg Med; 2013 Jan; 20(1):46-53. PubMed ID: 23570478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severity and outcomes of community acquired pneumonia in asthmatic patients.
    Terraneo S; Polverino E; Cilloniz C; Amaro R; Vennera Mdel C; Gabarrus A; Montull B; Moreno E; Menendez R; Centanni S; Torres A
    Respir Med; 2014 Nov; 108(11):1713-22. PubMed ID: 25245791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia.
    Hohenthal U; Hurme S; Helenius H; Heiro M; Meurman O; Nikoskelainen J; Kotilainen P
    Clin Microbiol Infect; 2009 Nov; 15(11):1026-32. PubMed ID: 19548923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.